Kyowa Hakko Kirin Submits ATL NDA In Japan
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin submitted a new drug application to the Ministry of Health, Labor and Welfare for KW-0761 for the treatment of adult T-cell leukemia-lymphoma